us indic start week strong note follow last week comment treasuri secretari steven mnuchin trade war us
china put hold major indic maintain open gain throughout session finish firm note crude
gold advanc within industri stock led pack
bottom line pre market open mu posit pre announc mayq rev/ep updat guidanc
midpoint vs prior midpoint guidanc importantli ep guidanc
preview roughli base current market price trend ep upsid simpli
driven market price alon rather better intern execut cost down manufactur mix end-
market exposur would highlight updat guidanc impli gm first time sinc augq
mark second time mu histori report note annual ep
analyst day later today expect mu place strong focu close technolog rel peer
emphas strategi around move bit higher valued-ad product system believ mayq ep upsid
clear indic intent continu argu mu becom sustain compani
higher trough repres one under-appreci asset semi
mayq posit pre suspect mayq rev/ep guidanc impli dram q/q vs cs flat market
trend q/q nand q/q vs cs q/q market trend q/q
dram bit flat q/q vs cs flat q/q nand bit q/q vs cs q/q dram cost down
q/q vs cs q/q nand cost down q/q vs cs q/q
capit return increasingli like expect mu net/cash mayq vs prior estim
febq continu believ mu like outlin framework capit
issu explicit buy-back author analyst day confid eventu buy-back
valuat increasingli attract continu argu upsid ev/fcf vs yr median
top decil quartil upsid warrant investor confid structur driver
unfold downsid look limit mu trade downturn-bas ep
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
attract design set path upsid rais target price
new announc de-risk design announc mavacamten trial
symptomat obstruct hypertroph cardiomyopathi enrol patient random receiv either mavacamten
placebo patient activ treatment arm start once-daili dose may titrat mg
daili week base measur provok lvot gradient primari endpoint trial clinic
respons week defin improv least peak accompani reduct
baselin least one nyha function class improv baselin greater peak
without worsen nyha function class trial expect commenc enrol result
respond analysi reduc risk placebo out-performance compani report patient
trial met clinic respond endpoint despit fact patient may optim dose given
dose explor natur trial trial power detect differ rel placebo valu
compani confid placebo respons rel trial expect
longer durat trial may prove advantag patient continu improv abl
physic activ
timelin look achiev first patient expect dose year compani guid data
base channel check clinician awar mavacamten appear high allow rapid trial
enrol may offer modest upsid timelin
reiter outperform rate rais tp increas po adjust launch
timelin late risk thesi includ clinic commerci regulatori headwind
electr ga util
buy gulf power po
sale like credit enhanc compani may announc agreement sell gulf power
compani florida citi ga fcg southern power interest fulli contract plant oleand ct
interest fulli contract plant stanton ccgt includ
debt financ transact debt note previous interest acquir
regul util either southeast mid-west seek respons deploy least balanc sheet
capac notabl expect chang deal like keep hunt addit
opportun expect maintain result increas credit capac asset
enhanc credit metric profil busi mix approach regul mix previous announc plan
reduc pre-work capit cfo/debt threshold mark expect similar
improv
accret less equiti expect ep accret bp improv ffo/debt
ep growth guidanc maintain plan increment equiti without block
accret doubl growth rate expect transact immedi accret upon close
accret ep respect result guidanc
continu expect reach top end new rang addit
accret transact asset expect grow earn twice rate
midpoint guidanc primarili increas capit invest opportun well roe oper
improv comparison latest guidanc ratebas growth across electr util
gulf power ratebas annual capital-expenditure fcg ratebas much smaller
valu depend kick util growth well beyond first glanc
transact price look immedi benefici valu proposit tie ramp growth
specif calcul healthi transact price-to-earnings combin electr ga util vs publicli
trade peer electr ga base disclos earn assum equiti plant
market reward higher yield
sinc begin year treasuri yield increas bp time
market advanc begun waiver
mani investor espous view higher rate caus higher volatil weaker perform
data clearli contradict assert specif market outperform day interest rate rise
rel rate day see
highlight feb note believ equiti continu reward higher yield point
receiv product pleas specifi credit suiss contact email call
headlin price previou day close unless otherwis note
compani mention price may
analyst identifi report certifi respect compani secur individu analyz
view express report accur reflect person view subject compani secur
part compens directli indirectli relat specif recommend
view express report
analyst respons prepar research report receiv compens base upon variou factor includ
credit suiss total revenu portion gener credit suiss invest bank activ
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel
analyst coverag univers consist compani cover analyst within relev sector outperform
repres attract neutral less attract underperform least attract invest opportun
octob canadian well european rate base stock total return rel
analyst coverag univers consist compani cover analyst within relev sector outperform
repres attract neutral less attract underperform least attract invest opportun
latin american asia stock exclud japan australia rate base stock total return rel
averag total return relev countri region benchmark india bse sensex index prior octob
 canadian rate base stock absolut total return potenti current share price
rel attract stock total return potenti within analyst coverag univers australian new zealand
stock expect total return calcul includ roll dividend yield outperform rate assign
greater equal under-perform less equal neutral may
assign overlap rate rang allow analyst assign rate put
context associ risk prior may rang outperform under-perform rate
overlap neutral threshold oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type
commun includ invest recommend cours credit suiss engag invest
bank transact certain circumst
volatil indic stock defin volatil stock price move month
least past month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect
fundament and/or valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover
credit suiss distribut stock rate bank client
purpos nyse nasd rate distribut disclosur requir stock rate outperform neutral under-perform
close correspond buy hold sell respect howev mean stock rate determin
rel basi pleas refer definit investor decis buy sell secur base invest object
current hold individu factor
credit suiss research report made avail client proprietari research portal cs credit
suiss research product may also made avail third-parti vendor altern electron mean
conveni certain research product made avail cs servic provid credit suiss
receiv product pleas specifi credit suiss contact email call
analyst client may depend specif client prefer regard frequenc manner receiv
commun client risk profil invest size scope overal client relationship firm
well legal regulatori constraint access credit suiss research entitl receiv
time manner pleas contact sale repres go http //plu credit-suiss com
credit suiss polici updat research report deem appropri base develop subject compani
sector market may materi impact research view opinion state herein
credit suiss polici publish invest research imparti independ clear fair mislead
detail pleas refer credit suiss polici manag conflict interest connect invest research
credit suiss provid tax advic statement herein regard us feder tax intend written
use use taxpay purpos avoid penalti
credit suiss decid enter busi relationship compani credit suiss determin
involv develop manufactur acquisit anti-personnel mine cluster munit credit suiss
posit issu pleas see http //www credit-suiss com/media/assets/corporate/docs/about-
